Abstract
Introduction
For many kinds of cancer, body composition and immunonutritional status have been reported to influence postoperative outcome. We assessed their impact on short- and long-term outcome in patients with colorectal liver metastases who underwent 2-stage liver resections.
Methods
Short- and long-term outcomes for 47 patients with 2-stage hepatectomies were assessed retrospectively in terms of data obtained before preoperative chemotherapy, before the first hepatectomy, and before the second hepatectomy.
Results
Although immunonutritional status and body composition did not affect short-term outcome, high intramuscular fat content before the second hepatectomy was a poor prognostic factor for overall survival (HR, 5.829; 95% CI, 1.611–21.090; p = 0.007) and for recurrence-free survival (HR, 2.787; 95% CI, 1.301–5.973; p = 0.008). Patients with high intramuscular fat before the second hepatectomy also showed shorter intervals from recurrence to treatment failure.
Conclusion
Intramuscular fat before the second hepatectomy is an important negative prognosticator in 2-stage liver resection for colorectal liver metastases.
Similar content being viewed by others
Abbreviations
- ALPPS:
-
Associating liver partition and portal vein occlusion for staged hepatectomy
- BMI:
-
Body mass index
- CI:
-
Confidence interval
- CRLM:
-
Colorectal liver metastases
- CT:
-
Computed tomography
- FLR:
-
Future liver remnant
- HR:
-
Hazard ratio
- ICGR15:
-
Indocyanine green retention rate at 15 min
- IMAC:
-
Intramuscular adipose tissue content
- ISGLS:
-
International Study Group of Liver Surgery
- NLR:
-
Neutrophil-lymphocyte ratio
- OS:
-
Overall survival
- PNI:
-
Prognostic nutritional index
- pre-CTx:
-
Before neoadjuvant chemotherapy
- pre-Hx1:
-
Before the first operation
- pre-Hx2:
-
Before the second operation
- PVE:
-
Portal vein embolization
- RFS:
-
Recurrence-free survival
- ROC:
-
Receiver operating characteristic
- ROI:
-
Region of interest
- SMI:
-
Skeletal muscle index
- TSH:
-
2-stage hepatectomy
- TTF:
-
Time to treatment failure
References
Pawlik TM, Schulick RD, Choti MA (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13:51–64
Ansari D, Bergenfeldt M, Tingstedt B, Andersson R (2012) Multimodal management of colorectal liver metastases and the effect on regeneration and outcome after liver resection. Scand J Gastroenterol 47:1460–1466
Adam R, Lauren A, Azoulay D et al (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785
Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405–414
Tanaka K, Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Endo I, Ichikawa Y, Taguri M, Tanabe M (2015) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity. Eur J Surg Oncol 41:506–512
Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, Azoulay D, Bismuth H, Castaing D, Adam R (2008) Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 248:994–1005
Pinto A, Hobeika H, Philis A et al (2019) Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? Langenbeck's Arch Surg 404:477–488
Ferrero A, Viganò L, Polastri R, Muratore A, Eminefendic H, Regge D, Capussotti L (2007) Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 31:1643–1651
Mizutani Y, Hirai T, Nagamachi S, Nanashima A, Yano K, Kondo K, Hiyoshi M, Imamura N, Terada T (2018) Prediction of posthepatectomy liver failure proposed by the International Study Group of Liver Surgery: residual liver function estimation with 99mTc-galactosyl human serum albumin scintigraphy. Clin Nucl Med 43:77–81
Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y, Nishie A, Yamanaka T (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 100:1523–1530
Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, Edil BH, Wolfgang CL, Schulick RD, Choti MA, Kamel I, Pawlik TM (2011) Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB 13:439–446
Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A (2011) Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg 98:268–274
McCluney SJ, Giakoustidis A, Segler A et al (2018) Neutrophil: lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis. J Surg Oncol 117:1058–1065
Haram A, Boland MR, Kelly ME, Bolger JC, Waldron RM, Kerin MJ (2017) The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review. J Surg Oncol 115:470–479
Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, Salloum C, Luciani A, Azoulay D (2015) Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 261:1173–1183
Okumura S, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Fujimoto Y, Iida T, Yagi S, Taura K, Hatano E, Okajima H, Uemoto S (2017) Impact of skeletal muscle mass, muscle quality, and visceral adiposity on outcomes following resection of intrahepatic cholangiocarcinoma. Ann Surg Oncol 24:1037–1045
Giakoustidis A, Neofytou K, Khan AZ, Mudan S (2015) Neutrophil to lymphocyte ratio predicts pattern of recurrence in patients undergoing liver resection for colorectal liver metastasis and thus the overall survival. J Surg Oncol 111:445–450
Kishiki T, Masaki T, Mastuoka H, Abe N, Mori T, Sugiyama M (2016) New prognostic scoring system for incurable stage IV colorectal cancer. Asian Pac J Cancer Prev 17:597–601
Lodewick TM, van Nijnatten TJ, van Dam RM et al (2015) Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB 17:438–446
Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, Tanaka T, Tomoda F (1994) A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 219:342–346
Tanaka K, Kikuchi Y, Kawaguchi D, Murakami T, Hiroshima Y, Matsuo K (2017) Modified ALPPS procedures avoiding division of portal pedicles. Ann Surg 265:e14–e20
Terminology Committee of the International Hepato-Pancreato-Biliary Association (2000) The Brisbane 2000 terminology of liver anatomy and resection. HPB 2:333–339
Hamaguchi Y, Kaido T, Okumura S, Ito T, Fujimoto Y, Ogawa K, Mori A, Hammad A, Hatano E, Uemoto S (2015) Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 22:475–485
Kitajima Y, Hyogo H, Sumida Y et al (2015) Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. J Gastroenterol Hepatol 28:1507–1514
Hamaguchi Y, Kaido T, Okumura S, Fujimoto Y, Ogawa K, Mori A, Hammad A, Tamai Y, Inagaki N, Uemoto S (2014) Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 20:1413–1419
Oba M, Hasegawa K, Matsuyama Y, Shindoh J, Mise Y, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M, Kokudo N (2014) Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure. Ann Surg Oncol 21:1817–1824
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724
Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M (2015) Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg 39:1494–1500
Okumura S, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Hatano E, Okajima H, Takaori K, Uemoto S (2017) Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer. Ann Surg Oncol 24:3732–3740
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423
Marcus RL, Addison O, Kidde JP, Dibble LE, Lastayo PC (2010) Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J Nutr Health Aging 14:362–366
Bharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, Jevenn A, Hanouneh I (2016) Malnutrition: laboratory markers vs nutritional assessment. Gastroenterology Report 4:272–280
Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, Sugano K, Hirakawa K (2015) The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer. BMC Cancer 15:521
Howard R, Kanetsky PA, Egan KM (2019) Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer. Sci Rep 9:19673
Templeton AJ, McNamara MG, Šeruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumours: a systematic review and meta-analysis. J Natl Cancer Inst 106. https://doi.org/10.1093/jnci/dju124.dju124
Martin L, Birdsell L, Macdonaid N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547
Montano-Loza AJ, Angulo P, Meza-junco J et al (2016) Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle 7:126–135
Rollins KE, Tewari N, Ackner A et al (2015) The impact of sarcopenia and myosteatosis on outcome of unresectable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr (Edinburgh, Scotland) 35: 1103-9
Malietzis G, Johns N, Al-Hassi HO et al (2015) Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer. Ann Surg 263:320–325
Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772–783
Park J, Morley TS, Kim M, Clegg DJ, Scherer PE (2014) Obesity and cancer - mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 10:455–465
Lutz CT, Quinn LBS (2012) Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY) 4:535–546
Bozzetti F (2020) Chemotherapy-induced sarcopenia. Curr Treat Options in Oncol 21:7
Almasud AA, Giles KH, Miklavcic JJ, Martins KJB, Baracos VE, Putman CT, Guan LL, Mazurak VC (2017) Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer. PLoS One 12:e0183576
Navarro J, Rho SY, Kang I, Choi GH, Min BS (2019) Robotic simultaneous resection for colorectal liver metastasis: feasibility for all types of liver resection. Langenbeck's Arch Surg 404:895–908
Eriksson S, Nilsson JH, Strandberg Holka P, Eberhard J, Keussen I, Sturesson C (2017) The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases. HPB 19:331–337
Author information
Authors and Affiliations
Contributions
Design: Tanaka. Acquisition of data: Shiozawa, Kikuchi, Wakabayashi, and Takahashi. Analysis and interpretation of data: Kikuchi, Wakabayashi, and Takahashi. Drafting the article: Shiozawa. Revising the article: Tanaka and Matsuo. Final approval: Tanaka.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shiozawa, T., Kikuchi, Y., Wakabayashi, T. et al. Body composition as reflected by intramuscular adipose tissue content may influence short- and long-term outcome following 2-stage liver resection for colorectal liver metastases. Langenbecks Arch Surg 405, 757–766 (2020). https://doi.org/10.1007/s00423-020-01973-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-020-01973-1